BASF has submitted the regulatory dossier for a new active ingredient, Revysol, to the European Union (EU). The proprietary compound is expected to be the company’s new blockbuster fungicide from the chemical class of triazoles (SBI). Extensive research has shown its outstanding biological performance against a range of difficult to control pathogens. Revysol’s submission for registration in the EU marks a key milestone towards the compound’s global registration in row and specialty crops.
“Undoubtedly, Revysol will be another striking compound that delivers significant benefits to farmers around the globe,” said Markus Heldt, President of BASF’s Crop Protection division. As farmers continue to need product diversity for mixing or alternating mode of actions, Revysol is set to play a vital role in future resistance management recommendations. “Our ability to develop such an excellent molecule definitely flags our leadership position in fungicides,” said Heldt.
Fungicides from the triazole chemical class have proven their value against diseases that can severely damage crops and compromise the quality of farmers’ harvests, such as Septoria tritici and rust in cereals. Nonetheless, no new molecule with this mode of action has
been introduced to the market for more than ten years, thus increasing the risk of resistance and leaving farmers with few alternatives for disease control.
“We have applied our deep fungicide expertise and invested best-inclass research to create Revysol,” said Harald Rang, Senior Vice President of Research and Development, BASF Crop Protection. Already at the discovery phase, the new fungicide was designed to meet both the highest level of regulatory standards and outstanding biological performance. “Farmers will have a new tool to ensure their crops will stay disease-free and healthy for a longer period of time, optimizing crop yields and quality of the harvest,” concluded Rang.
Revysol will be available in customized formulations to provide farmers worldwide with high performing fungicide solutions. Pending regulatory approval, first market introductions are expected for 2019.
